← Royal Fitness Club Educational information only — not a substitute for medical advice. Read disclaimer ·
Premium Health Platform Newsroom · Updated daily at 06:30 IST
Responsible medical news: prevention, risk reduction, safety alerts and evidence digests — with clear sources and no cure claims. Emergency symptoms always need immediate care, not a news article.
29 items in view · live official updates first, then evergreen guides
On 2 October 2026, WHO became aware through media reports of the death of an employee of the Irkutsk Antiplague Research Institute (APRI) of Siberia and the Far East, the Russian Federation.
World Health Organization — Disease Outbreak News
Read summary & source →On 5 October 2026, WHO was informed about a laboratory-confirmed imported case of Bundibugyo virus disease (BVD) in Kenya with travel history from the Democratic Republic of the Congo. The patient travelled from the Democratic Republic of the Congo to Kenya through Uganda.
Macleods Pharmaceuticals Limited, an Indian manufacturer, is recalling Olanzapine Tablets in the United States. Reason given: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
A new systematic review from India, published in BMJ open. Read the abstract on PubMed before drawing conclusions — one study rarely changes treatment on its own.
Since the last Disease Outbreak News was published on 11 September 2026, the Bundibugyo virus outbreak in the Democratic Republic of the Congo has expanded further, with two additional health zones affected.
Inventia Healthcare Limited, an Indian manufacturer, is recalling Chlorthalidone Tablets in the United States. Reason given: Failed Dissolution Specifications
Since the last Disease Outbreak News was published on 28 August 2026, the Bundibugyo virus outbreak in the Democratic Republic of the Congo has expanded to one additional health zone, Kayna, in North Kivu.
Since the last Disease Outbreak News was published on 14 August 2026, the outbreak has spread from 54 to 60 health zones. The number of affected provinces stands at six out of 26 provinces of the country: Bas-Uélé, Haut-Uélé, Ituri, North Kivu, South Kivu, and Tshopo.
Shilpa Medicare Limited, an Indian manufacturer, is recalling PEMRYDI RTU in the United States. Reason given: Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
Shoolin Pharma Chem LLP, an Indian manufacturer, is recalling SILDENAFIL CITRATE USP in the United States. Reason given: CGMP Deviations:Noted during FDA inspection
The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo is in a phase of intense transmission. It is the largest Ebola outbreak ever reported in the country and expanding faster than any previous Ebola outbreak.
The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo is intensifying, with sustained transmission and continued increases in reported cases and deaths.
JB Chemicals and Pharmaceuticals Ltd, an Indian manufacturer, is recalling Cetirizine Hydrochloride Tablets USP 5 mg in the United States. Reason given: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg.
The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo remains active, with sustained transmission driving increases in reported cases and deaths.
Shimoga Chemicals, an Indian manufacturer, is recalling Clomiphene Citrate USP Active Pharmaceutical Ingredient in the United States. Reason given: cGMP deviations
ONESOURCE SPECIALTY PHARMA LIMITED, an Indian manufacturer, is recalling Methohexital Sodium for Injection in the United States. Reason given: Failed Impurities/Degradation Specifications
Stagnant water in coolers, plant trays and tyre swings remains India's biggest breeding driver. A short structured check each week cuts exposure more than any spray.
Salt-water-sugar in correct amounts works where sports drinks and 'just water' can fail, especially for elders and people on diuretics.
PM2.5 spikes in North Indian winters reliably worsen cough, wheeze and BP control. Planning beats panic: spacer check, buffer days, masks that fit.
Fixed-dose steroid-antifungal combos sold over the counter keep worsening ringworm. Dermatologists urge prescription discipline and patient counselling.
Government wellness melas bring yoga counselling, NCD screening and Ayurvedic advice to villages. They work best as an entry point to follow-up, not a one-day fix.
Metabolic benefits follow consistent patterns — fibre, protein, fewer liquid calories — while single-food claims rarely survive controlled trials.
Self-started antibiotics mask diagnoses, break resistance and cause side effects. A short script of questions protects the whole household.
Breast self-awareness, clinical exam and symptom-first evaluation remain the practical Indian route; population mammography programmes are still early.
Late-night screen light, irregular meal timing and short sleep worsen insulin resistance faster than most diets improve it.
A yearly influenza vaccine discussion remains the simplest seasonal risk reducer for high-risk groups; check what is due and when.
Feeling cold or tired in December does not always mean your dose changed. TSH takes 6–8 weeks to reflect any real shift.
Persistent low mood or hopelessness in students needs a professional conversation early — not a motivational speech.
In Indian women, menstrual blood loss is a leading driver of iron deficiency. Treating the leak and the stores together is the fix.